| Code | 85984 | ||||||||||
| MA number | EU/1/95/002/001 | ||||||||||
| Product Form: | cif fol 1x0,5 ml/20 mg + 1,5 ml solv. (liek.skl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Sanofi Winthrop Industrie, France | ||||||||||
| Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | glass vial | ||||||||||
| Route of admin.: | Intravenous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application |
| MA issued: | 27.11.1995 |
| SmPC + PL: |
European Medicines Agency's database
|
| Dokument: |
DHPC Taxotere (docetaxel) 5 12 2011.pdf
|
| Dokument: |
DHPC Taxotere_01 12 2011.doc
|
| Safety feature | No |
| Data update: | 24.01.2019 |
